{"schema_version":"secwatch.filing_event.v1","accession":"0001210708-24-000052","form_type":"8-K","ticker":"STRR","cik":"0001210708","company_name":"Star Equity Holdings, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.582251+00:00","generated_at":"2026-06-01T02:42:35.012752+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Hudson Global extends NOL poison pill through October 2027, subject to stockholder approval","bullets":["Second Amendment to Rights Agreement extends term to October 15, 2027.","Stockholder approval required at 2024 annual meeting; without approval, amendment expires.","Rights trigger at 4.99% beneficial ownership to deter ownership changes under Section 382.","Any person or group exceeding 4.99% threshold has its rights voided and non-exercisable.","Plan aims to preserve Hudson's substantial net operating loss carryforwards and related tax benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001210708-24-000052","json":"https://secwatch.observer/filing/0001210708-24-000052.json","markdown":"https://secwatch.observer/filing/0001210708-24-000052.md","text":"https://secwatch.observer/filing/0001210708-24-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1210708/000121070824000052/0001210708-24-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1210708/000121070824000052/hson-20240618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:42:35.012752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}